key: cord-0799854-8l1cof7b
authors: Sadoughifar, Roxanna; Goldust, Mohamad; Kroumpouzos, George; Szepietowski, Jacek C.; Lotti, Torello; Sandhu, Sunmeet
title: Dermatologic treatments in the era of COVID‐19 pandemic—Data and Hypothesis
date: 2020-05-26
journal: Dermatol Ther
DOI: 10.1111/dth.13562
sha: c3acc2c89f5f5918638b564d20b1ce098dc9e6d3
doc_id: 799854
cord_uid: 8l1cof7b

nan

transmission to their practice. There have been a report of COVID-19 case with cutaneous manifestation. 4 Additionally, due to excessive use of personal hygiene products (sanitizer, soap, and hand rub) and prolonged use of personal protective equipment (PPE), various cutaneous conditions have emerged. Apart from the routine prevention, we will be focusing on the role of dermatologist and the changes made during this pandemic era to limit the disease transmission. continue such treatments should be guided by the severity of skin disease, comorbidities, and age of patient. At present, evidence for or against use of these agents is not very strong, but definite recommendations will be established as more data accumulate.

In conclusion, this pandemic has taught us that patient safety is of utmost importance and we should strive to achieve this goal. Der- 

Solidarity and transparency against the COVID-19 pandemic

The effect of quarantine and isolation for COVID-19 in general population and dermatologic treatments

Priorities for global health community in COVID-19 pandemic

COVID-19 can present with a rash and be mistaken for dengue

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China

Consensus of Chinese experts on protection of skin and mucous membrane barrier for healthcare workers fighting against coronavirus disease 2019

Dermatology practices as vectors for COVID-19 transmission: a call for immediate cessation of nonemergent dermatology visits

Letter from the editor: occupational skin disease among healthcare workers during the coronavirus (COVID-19) epidemic